// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Hemoglobin Requirements of Clinical Trials Involving Anemia in CKD and Implications on Future Work: A Systematic Literature Review

Farag YoussefMK - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

N/A

Treatment with β,γ-Methyleneadenosine 5′-Triphosphate Prevents Arterial Media Calcification in a Warfarin Rat Model

Opdebeeck Britt - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

Warfarin

Impaired Arterial Vitamin D Signaling Is Pathogenic in Vascular Calcification

Lim Kenneth - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Angiology

Calcified vascular disease

Paricalcitol

A Real-World Observational Study of Calcimimetic Use in Hemodialysis (HD) Patients with Secondary Hyperparathyroidism (SHPT) in Europe

Fouqueray Bruno - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Secondary hyperparathyroidism

Parathyroid hormone

Serum Biomarkers, but Not Dual-Energy X-ray Absorptiometry, Predict Cortical Bone Mineral Density in Children and Young Adults with CKD

Lalayiannis AlexanderD - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bone Mineral Density Is Not Associated with Coronary Artery Calcification in Children and Young Adults with CKD

Lalayiannis AlexanderD - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Complex calcified coronary artery lesions

N/A

Clinical Characteristics and eGFR and Urine Albumin-to-Creatinine Ratio Distribution According to the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD International Retrospective Cohort

Garcia Sanchez Juan Jose - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

The DAPA-CKD-Like Population in a Contemporary US Healthcare System: Cohort Characteristics and Clinical Outcomes

Olufade Tope - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Polycystic kidney disease

N/A

Defining the Excess Risk of Adverse Kidney Outcomes in CKD Patients with Type 2 Diabetes in the DISCOVER-CKD Cohort

Abdul Sultan Alyshah - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Microvascular complications of diabetes 1

N/A

Baseline Characteristics of Non-Dialysis CKD Patients with and Without Anemia: A Report from the Retrospective Cohort from DISCOVER CKD

Wittbrodt EricT - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Anemia

N/A

Healthcare Resource Utilisation and Costs of CKD According to the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD Retrospective Cohort

Garcia Sanchez Juan Jose - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Healthcare Resource Utilization and Costs in a DAPA-CKD-Like Population Using a Contemporary US Healthcare Cohort

Olufade Tope - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Treatment Pathways of CKD Patients Defined by the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD Retrospective Cohort

Garcia Sanchez Juan Jose - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Treatment Pathways of Patients with CKD: A Report from the DISCOVER CKD Retrospective Cohort

James Glen - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

Rates of Clinical Events in Patients with CKD: A UK Population-Based Cohort Study

Abdul Sultan Alyshah - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Estimating the Future Burden of CKD Through Microsimulation Methods

Retat Lise - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Albuminuria

N/A

Identifying and Clustering CKD Progression Trajectories Using Machine Learning

Abdul Sultan Alyshah - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluation of Thromboelastometry and Multiple Electrode Aggregometry in ESRD

Abdelmaguid Alyaa - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

Evithrom

Pegunigalsidase Alfa, Novel Pegylated Enzyme Replacement Therapy, Evaluated in Fabry Patients with Progressing Kidney Disease: A Randomized Clinical Trial Study Design

Warnock DavidG - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Renal disease

Agalsidase beta

Pegunigalsidase Alfa, PEGylated α-Galactosidase-A Enzyme in Development for the Treatment of Fabry Disease, Shows a Correlation Between Renal Gb3 Inclusion Clearance and Reduction of Plasma Lyso-Gb3

Tuffaha AhmadM - American Society of Nephrology (ASN) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Fabry disease

N/A

Copyright © 2026. QuantiNova All rights reserved